KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Short-term Investments (2020 - 2025)

Clover Health Investments' Short-term Investments history spans 6 years, with the latest figure at $17.0 million for Q4 2025.

  • For Q4 2025, Short-term Investments rose 113546.67% year-over-year to $17.0 million; the TTM value through Dec 2025 reached $17.0 million, up 113546.67%, while the annual FY2025 figure was $17.0 million, 113546.67% up from the prior year.
  • Short-term Investments reached $17.0 million in Q4 2025 per CLOV's latest filing, up from $11.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $212.3 million in Q1 2022 to a low of $15000.0 in Q1 2023.
  • Average Short-term Investments over 5 years is $43.4 million, with a median of $11.6 million recorded in 2023.
  • Peak YoY movement for Short-term Investments: tumbled 99.99% in 2023, then soared 786940.0% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $21.1 million in 2021, then soared by 375.61% to $100.5 million in 2022, then crashed by 87.84% to $12.2 million in 2023, then tumbled by 99.88% to $15000.0 in 2024, then skyrocketed by 113546.67% to $17.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Short-term Investments are $17.0 million (Q4 2025), $11.0 million (Q3 2025), and $1.8 million (Q2 2025).